Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 43

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 43
---
 | any                                                                                          
 underwriting discounts, commissions and other items constituting underwriters’ compensation; |

| ● | any                            
 initial public offering price; |

| ● | any                                                               
 discounts or concessions allowed or reallowed or paid to dealers; |

| ● | any                             
 commissions paid to agents; and |

| ● | any                                                                  
 securities exchange or market on which the securities may be listed. |

Sale Through Underwriters or Dealers

Only underwriters named in the prospectus supplement
are underwriters of the securities offered by the prospectus supplement.

<div align='center'>10</div>

If underwriters are used in the sale, the underwriters
will acquire the securities for their own account, including through underwriting, purchase, security lending or repurchase agreements
with us. The underwriters may resell the securities from time to time in one or more transactions, including negotiated transactions.
Underwriters may sell the securities in order to facilitate transactions in any of our other securities (described in this prospectus
or otherwise), including other public or private transactions and short sales. Underwriters may offer securities to the public either
through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters.
Unless otherwise indicated in the prospectus supplement, the obligations of the underwriters to purchase the securities will be subject
to certain conditions, and the underwriters will be obligated to purchase all the offered securities if they purchase any of them. The
underwriters may change from time to time any initial public offering price and any discounts or concessions allowed or reallowed or paid
to dealers.

If dealers are used in the sale of securities offered
through this prospectus, we will sell the securities to them as principals. They may then resell those securities to the public at varying
prices determined by the dealers at the time of resale. The prospectus supplement will include the names of the dealers and the terms
of the transaction.

Direct Sales and Sales Through Agents

We may sell the securities offered through this
prospectus directly. In this case, no underwriters or agents would be involved. Such securities may also be sold through agents designated
from time to time. The prospectus supplement will name any agent involved in the offer or sale of the offered securities and will describe
any commissions payable to the agent. Unless otherwise indicated in the prospectus supplement, any agent will agree to use its reasonable
best efforts to solicit purchases for the period of its appointment.

We may sell the